Cargando…

Expression of p53 predicts risk of prevalent and incident advanced neoplasia in patients with Barrett's esophagus and epithelial changes indefinite for dysplasia

Background and aims: Patients with Barrett’s esophagus (BE) are at an increased risk for developing esophageal adenocarcinoma (EAC); thus they may undergo regular endoscopic surveillance. If epithelial changes cannot be unequivocally classified as negative or positive for dysplasia, a diagnosis of i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horvath, Bela, Singh, Prabhdeep, Xie, Hao, Thota, Prashanthi N, Sun, Xingwen, Liu, Xiuli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193059/ https://www.ncbi.nlm.nih.gov/pubmed/26486567 http://dx.doi.org/10.1093/gastro/gov045

Ejemplares similares

The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study
por: Phillips, Richard, et al.
Publicado: (2021)

“Indefinite for Dysplasia” in Barrett's Esophagus: Inflammation and DNA Content Abnormality are Significant Predictors of Early Detection of Neoplasia
por: Choi, Won-Tak, et al.
Publicado: (2015)

Overexpression of p53 predicts colorectal neoplasia risk in patients with inflammatory bowel disease and mucosa changes indefinite for dysplasia
por: Horvath, Bela, et al.
Publicado: (2015)

The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia
por: Januszewicz, Wladyslaw, et al.
Publicado: (2022)

Barrett's Esophagus in Rubinstein-Taybi Syndrome
por: Kumar, Prabhat, et al.
Publicado: (2020)

Barrett’s esophagus: novel strategies for screening and surveillance
por: Sanghi, Vedha, et al.
Publicado: (2019)

Chemoprevention in Barrett’s esophagus and esophageal adenocarcinoma
por: Alkhayyat, Motasem, et al.
Publicado: (2021)

Histopathology in Barrett Esophagus and Barrett Esophagus-Related Dysplasia
por: Grin, Andrea, et al.
Publicado: (2014)

Risk of progression of Barrett's esophagus in patients with cirrhosis
por: Apfel, Tehilla, et al.
Publicado: (2017)

Treatment of Dysplasia in Barrett Esophagus
por: Aranda-Hernandez, Javier, et al.
Publicado: (2014)

Management of nondysplastic Barrett’s esophagus: When to survey? When to ablate?
por: Puthenpura, Max M., et al.
Publicado: (2022)

Higher prevalence of colon polyps in patients with Barrett’s esophagus: a case-control study
por: Kumaravel, Arthi, et al.
Publicado: (2014)

Higher risk of neoplastic progression of Barrett’s esophagus in patients with systemic sclerosis
por: Anilkumar, Mythri, et al.
Publicado: (2021)

Indications, contraindications and limitations of endoscopic therapy for Barrett’s esophagus and early esophageal adenocarcinoma
por: Rouphael, Carol, et al.
Publicado: (2020)

Incidence of Dysplasia in Obese vs Nonobese Patients With Nondysplastic Barrett Esophagus
por: Monardo, Ann, et al.
Publicado: (2019)

Low-grade dysplasia on Barrett’s esophagus: visible or not ?
por: Barret, Maximilien
Publicado: (2023)

Endoscopic therapy for Barrett’s esophagus and early esophageal cancer: Where do we go from here?
por: Singh, Tavankit, et al.
Publicado: (2018)

Metastatic melanoma in an esophagus demonstrating Barrett esophagus with high grade dysplasia
por: Trembath, Dimitri G, et al.
Publicado: (2013)

The incidence of esophageal cancer and dysplasia in a Chinese population with nondysplastic Barrett's esophagus
por: Lee, Shou‐Wu, et al.
Publicado: (2018)

Longitudinal and Circumferential Distributions of Dysplasia and Early Neoplasia in Barrett's Esophagus: A Pooled Analysis of Three Prospective Studies
por: Raphael, Kara L., et al.
Publicado: (2021)

Management of Barrett’s esophagus with dysplasia refractory to radiofrequency ablation
por: Raphael, Kara L, et al.
Publicado: (2020)

A Multiscale Model Evaluates Screening for Neoplasia in Barrett’s Esophagus
por: Curtius, Kit, et al.
Publicado: (2015)

Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus
por: Waterhouse, Dale J., et al.
Publicado: (2021)

Role of artificial intelligence in diagnosing Barrett’s esophagus-related neoplasia
por: Meinikheim, Michael, et al.
Publicado: (2023)

Abnormal TP53 Predicts Risk of Progression in Patients With Barrett’s Esophagus Regardless of a Diagnosis of Dysplasia
por: Redston, Mark, et al.
Publicado: (2022)

Laparoscopic Transhiatal Esophagectomy for Barrett's Esophagus with High Grade Dysplasia
por: Luketich, James D., et al.
Publicado: (1998)

Endoscopic Diagnosis and Management of Barrett’s Esophagus with Low-Grade Dysplasia
por: Maione, Francesco, et al.
Publicado: (2022)

Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States
por: Sharma, Prateek, et al.
Publicado: (2023)

Wide-field endoscopic submucosal dissection for the treatment of Barrett’s esophagus neoplasia
por: Omae, Masami, et al.
Publicado: (2021)

Mutational load may predict risk of progression in patients with Barrett’s oesophagus and indefinite for dysplasia: a pilot study
por: Trindade, Arvind J, et al.
Publicado: (2019)

Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance
por: Mahmoud, Remi, et al.
Publicado: (2019)

Length of Barrett’s esophagus in the presence of low-grade dysplasia, high-grade dysplasia, and adenocarcinoma
por: Barrie, Jenifer, et al.
Publicado: (2020)

Identification of a key role of widespread epigenetic drift in Barrett’s esophagus and esophageal adenocarcinoma
por: Luebeck, E. Georg, et al.
Publicado: (2017)

Advanced Imaging Technologies for the Detection of Dysplasia and Early Cancer in Barrett Esophagus
por: Espino, Alberto, et al.
Publicado: (2014)

Barrett’s esophagus with high grade dysplasia is associated with non-esophageal cancer
por: Bar, Nir, et al.
Publicado: (2018)

Buried Barrett’s Esophagus with High-Grade Dysplasia after Radiofrequency Ablation
por: Castela, Joana, et al.
Publicado: (2019)

Utility of ancillary studies in the diagnosis and risk assessment of Barrett’s esophagus and dysplasia
por: Choi, Won-Tak, et al.
Publicado: (2022)

Barrett's esophagus : columnar lined esophagus
Publicado: (2003)

A nonrandomized trial of vitamin D supplementation for Barrett’s esophagus
por: Cummings, Linda C., et al.
Publicado: (2017)

Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett’s esophagus biopsies – towards digital review of Barrett’s esophagus
por: van der Wel, MJ, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9b8k91oakqdhvnk3ona8eqfeku